Aspen to sell major Asia Pacific assets to Australian firm for R26bn
Aspen Pharmacare, South Africa’s biggest pharmaceutical producer, will sell its major Asia Pacific assets, excluding China, to Australian private equity firm BGH Capital for A$2.37bn (R26.45bn), the group said on Monday.
Black News 
Aspen Pharmacare, South Africa’s biggest pharmaceutical producer, will sell its major Asia Pacific assets, excluding China, to Australian private equity firm BGH Capital for A$2.37bn (R26.45bn), the group said on Monday.
